Aloysius Romero Domingo, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dystonic Disorders | 29 | 2023 | 329 | 6.490 |
Why?
|
| Genetic Diseases, X-Linked | 23 | 2022 | 372 | 4.600 |
Why?
|
| Dystonia | 5 | 2021 | 363 | 2.070 |
Why?
|
| Parkinsonian Disorders | 4 | 2020 | 275 | 0.960 |
Why?
|
| Transcription Factor TFIID | 5 | 2019 | 151 | 0.910 |
Why?
|
| TATA-Binding Protein Associated Factors | 5 | 2019 | 104 | 0.890 |
Why?
|
| Histone Acetyltransferases | 5 | 2019 | 336 | 0.820 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2021 | 1157 | 0.710 |
Why?
|
| Movement Disorders | 2 | 2020 | 445 | 0.680 |
Why?
|
| Myelin Sheath | 1 | 2021 | 652 | 0.610 |
Why?
|
| Basal Ganglia Diseases | 4 | 2019 | 149 | 0.540 |
Why?
|
| Parkinson Disease | 4 | 2018 | 2775 | 0.530 |
Why?
|
| Sequence Analysis | 1 | 2016 | 256 | 0.520 |
Why?
|
| Chromosomes, Human, X | 2 | 2015 | 296 | 0.470 |
Why?
|
| Agammaglobulinemia | 1 | 2014 | 167 | 0.440 |
Why?
|
| Mutation | 12 | 2021 | 29786 | 0.350 |
Why?
|
| Basal Ganglia | 4 | 2023 | 546 | 0.350 |
Why?
|
| Genetic Linkage | 1 | 2015 | 2421 | 0.340 |
Why?
|
| Philippines | 4 | 2019 | 86 | 0.330 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 9648 | 0.310 |
Why?
|
| Hearing Loss | 1 | 2014 | 765 | 0.290 |
Why?
|
| Nerve Degeneration | 3 | 2019 | 748 | 0.270 |
Why?
|
| Neurodegenerative Diseases | 3 | 2023 | 1061 | 0.260 |
Why?
|
| Genetic Variation | 1 | 2018 | 6544 | 0.210 |
Why?
|
| Calcinosis | 3 | 2016 | 1499 | 0.210 |
Why?
|
| Corpus Striatum | 2 | 2018 | 1221 | 0.200 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type III | 2 | 2021 | 7 | 0.200 |
Why?
|
| Protein Kinases | 2 | 2018 | 1640 | 0.190 |
Why?
|
| Putamen | 2 | 2019 | 291 | 0.180 |
Why?
|
| Pedigree | 4 | 2016 | 4644 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 17446 | 0.170 |
Why?
|
| Penetrance | 1 | 2021 | 381 | 0.170 |
Why?
|
| Molecular Chaperones | 2 | 2021 | 742 | 0.170 |
Why?
|
| Brain Diseases | 2 | 2021 | 1563 | 0.170 |
Why?
|
| DNA Repeat Expansion | 1 | 2019 | 66 | 0.170 |
Why?
|
| Disease Progression | 2 | 2017 | 13284 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2018 | 1861 | 0.160 |
Why?
|
| Globus Pallidus | 1 | 2019 | 253 | 0.150 |
Why?
|
| Ocular Motility Disorders | 1 | 2018 | 135 | 0.150 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 798 | 0.150 |
Why?
|
| Tubulin | 2 | 2018 | 695 | 0.150 |
Why?
|
| Striatonigral Degeneration | 1 | 2016 | 13 | 0.150 |
Why?
|
| Hemiplegia | 1 | 2016 | 135 | 0.140 |
Why?
|
| Evoked Potentials | 2 | 2018 | 1056 | 0.130 |
Why?
|
| Cerebellar Ataxia | 1 | 2016 | 145 | 0.130 |
Why?
|
| Substantia Nigra | 1 | 2017 | 353 | 0.130 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 377 | 0.130 |
Why?
|
| Humans | 40 | 2023 | 744343 | 0.120 |
Why?
|
| Impulsive Behavior | 1 | 2017 | 316 | 0.120 |
Why?
|
| Genetic Loci | 2 | 2021 | 2575 | 0.120 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2015 | 246 | 0.120 |
Why?
|
| Torticollis | 1 | 2014 | 66 | 0.120 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2014 | 100 | 0.110 |
Why?
|
| Alleles | 2 | 2021 | 6933 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2013 | 251 | 0.110 |
Why?
|
| X Chromosome Inactivation | 1 | 2014 | 224 | 0.110 |
Why?
|
| Haplotypes | 2 | 2018 | 2779 | 0.100 |
Why?
|
| Turner Syndrome | 1 | 2013 | 130 | 0.100 |
Why?
|
| Phenotype | 6 | 2022 | 16365 | 0.100 |
Why?
|
| alpha-Synuclein | 1 | 2018 | 723 | 0.100 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 2703 | 0.100 |
Why?
|
| Atrophy | 3 | 2023 | 1583 | 0.100 |
Why?
|
| Family Health | 1 | 2016 | 1282 | 0.100 |
Why?
|
| Cerebellum | 1 | 2018 | 1488 | 0.100 |
Why?
|
| Data Collection | 1 | 2020 | 3341 | 0.100 |
Why?
|
| Neural Inhibition | 1 | 2015 | 602 | 0.100 |
Why?
|
| Deep Brain Stimulation | 1 | 2019 | 748 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2017 | 1312 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2018 | 1736 | 0.090 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 1901 | 0.090 |
Why?
|
| Linkage Disequilibrium | 1 | 2015 | 1997 | 0.090 |
Why?
|
| Middle Aged | 19 | 2021 | 213383 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 1783 | 0.090 |
Why?
|
| Male | 24 | 2021 | 350118 | 0.080 |
Why?
|
| Genotype | 2 | 2021 | 12951 | 0.080 |
Why?
|
| Adult | 20 | 2023 | 214055 | 0.080 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 2147 | 0.080 |
Why?
|
| Motor Cortex | 1 | 2015 | 986 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1708 | 0.070 |
Why?
|
| Age of Onset | 3 | 2021 | 3271 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2017 | 2972 | 0.070 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 4740 | 0.070 |
Why?
|
| Serbia | 2 | 2016 | 15 | 0.070 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2015 | 1432 | 0.060 |
Why?
|
| Genome, Human | 1 | 2018 | 4420 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 2018 | 5708 | 0.060 |
Why?
|
| Aged | 7 | 2021 | 163280 | 0.060 |
Why?
|
| Germany | 2 | 2019 | 862 | 0.060 |
Why?
|
| Genetic Testing | 2 | 2014 | 3444 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 4328 | 0.060 |
Why?
|
| Case-Control Studies | 5 | 2021 | 21746 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2017 | 5985 | 0.060 |
Why?
|
| Decision Making | 1 | 2017 | 3887 | 0.060 |
Why?
|
| Iron | 2 | 2023 | 1774 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 35421 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2017 | 4043 | 0.050 |
Why?
|
| Genes, sis | 1 | 2021 | 3 | 0.050 |
Why?
|
| Reaction Time | 2 | 2018 | 2097 | 0.050 |
Why?
|
| Functional Laterality | 2 | 2018 | 2290 | 0.050 |
Why?
|
| Sex Factors | 1 | 2014 | 10397 | 0.050 |
Why?
|
| Young Adult | 5 | 2021 | 56430 | 0.050 |
Why?
|
| Growth Differentiation Factor 3 | 1 | 2018 | 11 | 0.040 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2018 | 40 | 0.040 |
Why?
|
| Female | 14 | 2019 | 380194 | 0.040 |
Why?
|
| Electroencephalography | 3 | 2018 | 6150 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2021 | 426 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4186 | 0.040 |
Why?
|
| Alu Elements | 1 | 2018 | 119 | 0.040 |
Why?
|
| Caudate Nucleus | 1 | 2019 | 393 | 0.040 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2018 | 223 | 0.040 |
Why?
|
| Antiparkinson Agents | 1 | 2018 | 184 | 0.040 |
Why?
|
| Minisatellite Repeats | 1 | 2018 | 165 | 0.040 |
Why?
|
| Endophenotypes | 1 | 2018 | 250 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2018 | 284 | 0.040 |
Why?
|
| Mice | 2 | 2021 | 81183 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15540 | 0.030 |
Why?
|
| Videotape Recording | 1 | 2017 | 352 | 0.030 |
Why?
|
| Introns | 1 | 2018 | 991 | 0.030 |
Why?
|
| Heterozygote | 1 | 2021 | 2804 | 0.030 |
Why?
|
| Brain Waves | 1 | 2018 | 401 | 0.030 |
Why?
|
| Animals | 3 | 2021 | 168757 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 176 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2018 | 13033 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 1265 | 0.030 |
Why?
|
| Serine | 1 | 2016 | 826 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2016 | 1590 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1117 | 0.030 |
Why?
|
| Brain Mapping | 2 | 2018 | 6669 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2015 | 930 | 0.030 |
Why?
|
| Electromyography | 1 | 2016 | 1379 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 851 | 0.020 |
Why?
|
| Brain | 4 | 2021 | 26385 | 0.020 |
Why?
|
| International Cooperation | 1 | 2017 | 1420 | 0.020 |
Why?
|
| Transfection | 1 | 2018 | 5892 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2017 | 8949 | 0.020 |
Why?
|
| Japan | 1 | 2014 | 1360 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2018 | 6365 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 1791 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2018 | 3494 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5952 | 0.020 |
Why?
|
| Family | 1 | 2018 | 3147 | 0.020 |
Why?
|
| Base Sequence | 1 | 2018 | 12797 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 7799 | 0.020 |
Why?
|
| Affect | 1 | 2014 | 1476 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3597 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 4462 | 0.020 |
Why?
|
| Child | 3 | 2021 | 77709 | 0.020 |
Why?
|
| Adolescent | 3 | 2021 | 85781 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2018 | 40561 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2737 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 19229 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12261 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 13815 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 15519 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 18111 | 0.010 |
Why?
|
| Neurons | 1 | 2018 | 9338 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14557 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39050 | 0.010 |
Why?
|
| Cognition | 1 | 2014 | 6770 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 18029 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20129 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 57776 | 0.010 |
Why?
|